Open Access
Endosc Int Open 2015; 03(04): E323-E328
DOI: 10.1055/s-0034-1391666
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Diagnosis of bile duct cancer by bile cytology: usefulness of post-brushing biliary lavage fluid

Shinya Sugimoto
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Hiroyuki Matsubayashi
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Hirokazu Kimura
2   Division of Molecular Biology and Biochemistry, Graduate School of Medicine, Osaka University, Osaka, Japan
,
Keiko Sasaki
3   Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan
,
Kaori Nagata
3   Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan
,
Sachiyo Ohno
3   Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan
,
Katsuhiko Uesaka
4   Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan
,
Keita Mori
5   Division of Clinical Trials, Shizuoka Cancer Center, Shizuoka, Japan
,
Kenichiro Imai
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Kinichi Hotta
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Kohei Takizawa
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Naomi Kakushima
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Masaki Tanaka
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Noboru Kawata
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
,
Hiroyuki Ono
1   Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 21. Oktober 2014

accepted after revision 31. Oktober 2014

Publikationsdatum:
07. Mai 2015 (online)

Preview

Background: Pathologic evidence of biliary diseases can be obtained from cytology in addition to endoscopic retrograde cholangiopancreatography (ERCP); however, the diagnostic effectiveness is not satisfactory.

Study aim: This retrospective, single-center study evaluated the efficacy of various sampling methods for the cytologic diagnosis of bile duct cancer.

Patients and methods: Biliary samples included bile that was simply aspirated, brush smear, brush-rinsed saline, and post-brushing biliary lavage fluid. A set of samples was compared for cytologic efficacy in 76 patients with surgically proven bile duct cancer and in 50 patients with benign biliary stricture.

Results: The cytologic sensitivity for diagnosing biliary cancer was 34 % with aspirated bile, 32 % with brush smear, 43 % with brush-rinsed saline, and 70 % with post-brushing biliary lavage fluid, in contrast to the null false-positive result in the benign cases. The sensitivity of cytology was significantly higher with post-brushing lavage fluid than with the other three sampling methods (P < 0.0001), and post-brushing lavage fluid improved the cumulative sensitivity by 24 % (P = 0.002). The sensitivity of biliary cytology was also associated with the amount of aspirated bile (P = 0.01) and with the aspiration site (P = 0.03). The rate of cancer positivity in a cytology set differed according to the tumor macroscopic type (85 % in the protruding type vs. 40 % in the flat type; P = 0.003), and according to the size of the cancer (87 % for tumors ≥ 50 mm vs. 66 % for tumors < 50 mm; P = 0.02).

Conclusions: Post-brushing biliary lavage fluid cytology provides superior diagnostic efficacy, and its addition to ERCP procedures is recommended for obtaining cytologic evidence of bile duct cancer.